WallStSmart
CRDL

Cardiol Therapeutics Inc Class A

NASDAQ: CRDL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.38
+5.34% today

Updated 2026-04-30

Market cap
$156.35M
P/E ratio
P/S ratio
1,014.87x
EPS (TTM)
$-0.29
Dividend yield
52W range
$1 – $2
Volume
0.8M

Cardiol Therapeutics Inc Class A (CRDL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$0.00$78760.00$62267.00$0.00$0.00$0.00$0.00
Revenue growth (YoY)-20.9%-100.0%
Cost of revenue$53341.00$91492.00$116114.00$180171.00$174264.00$162226.00$187383.00
Gross profit$-53341.00$-91492.00$-116114.00$-180171.00$-111997.00$-162226.00$-187383.00
Gross margin-228.8%-179.9%
R&D$441257.00$1.53M$2.72M$8.25M$8.59M$13.99M$10.73M$14.01M$14.02M
SG&A$1.10M$5.87M$10.45M$9.95M$27.87M$22.37M$15.56M$26.26M$20.20M
Operating income$-1.59M$-7.39M$-10.89M$-16.24M$-30.57M$-30.49M$-22.47M$-40.28M$-34.32M
Operating margin-20620.3%-49092.4%
EBITDA$-1.50M$-7.30M$-10.44M$-16.02M$-24.84M$-22.66M$-21.04M$-40.11M$-34.21M
EBITDA margin-20342.2%-39891.0%
EBIT$-1.56M$-7.39M$-10.55M$-16.20M$-25.01M$-22.82M$-21.22M$-40.28M$-34.32M
Interest expense$60562.00$663373.00$621.00$0.00$0.00
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-1.66M$-15.89M$-10.55M$-16.20M$-25.01M$-22.82M$-21.22M$-36.68M$-33.82M
Net income growth (YoY)-856.9%+33.6%-53.5%-54.4%+8.8%+7.0%-72.8%+7.8%
Profit margin-20570.9%-40170.9%